Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 639-566-4 | CAS number: 165184-98-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- 1973
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- Amylcinnamaldehyde is structurally very close to hexylcinnamaldehyde and therefore read-across is justified. It is expected that both substances will exhibit a similar pattern of toxicity. Further supporting documentation is included within the endpoint summary. This is a published study which contains sufficient detail, including in results, to judge it reliable for hazard assessment purposes. Non GLP but close to guideline study and well documented.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 973
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- no opthalmological examination; No sensory reactivity determination; some serum determinations not conducted i.e. creatinine, cholesterol, sodium and potassium. Some organ histology not conducted .
- GLP compliance:
- no
- Limit test:
- no
Test material
- Details on test material:
- - Name of test material (as cited in study report):Amyl cinnamic aldehyde (supplied by Bush Boake Allen Ltd, London); alpha-amylcinnamaldehyde; alpha-penylcinnamaldehyde; 2-pentyl-3-phenyl prop-2-enal.
- Molecular formula (if other than submission substance): C6H5-CH=C(CH2-(CH2)3-CH3)-CHO
- Physical state: pale yellow liquid
- Analytical purity: min. 97%
- Other: specific gravity (25C) , 0.963-0.968; refractive index (20C) 1.552-1.559; acid number, max 5.0.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: CFE
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: SPF breeding colony (not clear whether sourced at BIBRA)
- Age at study initiation: no data
- Weight at study initiation: males 100-125g; females 90-120g
- Fasting period before study:
- Housing: 5 per cage
- Diet (e.g. ad libitum): Ad libitum. Spillers' Laboratory Small Diet.
- Water (e.g. ad libitum): Ad libitum.
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21+/-1C
- Humidity (%): 50-60%
- Air changes (per hr): no data
- Photoperiod (hrs dark / hrs light): no data
IN-LIFE DATES: From: To: no data
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- other: diet
- Details on oral exposure:
- The loss of amyl cinnamic aldehyde from the diet was determined prior to the study. This was done by the analysis (gas chromatography) of a diet which had been prepared with amyl cinnamic aldehyde at 10,000ppm and had been exposed in the animal room for 48, and compared to the same mixture in an air tight container. Only 1% of amyl cinnamic aldehyde was lost from the diet. Since this was not considered significant amy cinnamic aldehyde was administered in food prepared every 4-5 days with the appropriate concentrations.
- Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 14 weeks
- Frequency of treatment:
- Continuous
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 80, 400, or 4000 ppm
Basis:
nominal in diet
- No. of animals per sex per dose:
- 15 for 14 weeks treatment (0, 80, 400, or 4000ppm)
Additional 5 for 2 weeks treatment (0, 400, or 4000ppm)
Additional 5 for 6 weeks treatment (0, 400, or 4000ppm) - Control animals:
- yes, plain diet
- Details on study design:
- no data
- Positive control:
- none
Examinations
- Observations and examinations performed and frequency:
- Body weights: At the beginning of the study and then weekly up to week 14.
Food and water consumption were measured over the 24hour period preceding each weighing. - Sacrifice and pathology:
- At completion of the study the animals were necropsied. Any macroscopic abnormalities were noted.
The following organs were weighed: brain, pituitary, thyroid, heart, liver, spleen, kidneys, adrenals, gonads, stomach, small intestine and caecum.
Samples of the organs weighed were histologically examined. Also, tissues and samples from the following were histologically examined: salivary gland, trachea, aorta, thymus, lymph nodes, urinary bladder, colon, rectum, pancreas, uterus, skeletal muscle, and any other tissue that appeared to be abnormal. - Other examinations:
- Bloods were obtained before necropsy for haematological and serum chemistry investigations. In the final week of treatment, urine produced in a 6 hour period of water deprivation. At week 6 and 13, urine over a 2hr period was collected following a 25ml/kg of waterload and between 16 and 20hr after the water load.
- Statistics:
- Student's t-test. Significantce p<0.05 or p<001
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- not examined
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- Liver and kidney
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Description (incidence and severity):
- mammary adenomas
- Details on results:
- One female in the 400ppm group died but histological and necropsy findings showed to be due to infection and therefore, unrelated to treatment.
Mammary adenomas were noted in two females (1 at 80ppm and 1 at 400ppm) during the last 3 week of the study. These were considered spontaneous and non-treatment related.
Significant lower stomach weights in males given 400ppm and lower small-intestine weights in females given 4000ppm were observed after treatment for 6 weeks. The latter was not significant when expressed per body weight. Also, there were significant increases in relative liver weights in both sexes after 14week treatment and in males after 6 week treatement. Relative kidney weights were also increased after 14weeks at 4000ppm.
There were some macroscopic and histological findings but none associated with substance intake. These were red, patchy lungs in three male rats (two at 80ppm, one in control), and pale kidneys in some male rats in all groups including controls. Also, vacuolation of some liver cells, protein casts in the kidney tubules and signs of chronic lung infection, with low and similar incidence in both treated and controls.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 400 ppm
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: Liver and kidney enlargement observed at 4000 ppm
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
The increase in relative liver and kidney weights was not associated with any histological abnormality.
Mean intakes of amyl cinnamic aldehyde were 6.1, 29.9 and 287.3 mg/kg/day for males and 6.7, 34.9, and 320.3 mg/kg/day for females.
The 400 ppm NOAEL corresponded to approximately 23 mg/kg/day in males and 36mg/kg/day in females, ~30mg/kg/day for both.
Applicant's summary and conclusion
- Conclusions:
- An oral NOAEL of 30mg/kg/day can be derived under the conditions of this study.
- Executive summary:
This study is included as read-across from amyl cinnamaldehyde. Male and female rats were fed a diet containing amyl cinnamic aldehyde at 0, 80, 400 or 4000 ppm for 14 weeks. No differences were observed in body weight gain, haematology, urinary analysis, or clinical chemistry between control and treatment groups. Macroscopic and histological examination did not find any treatment-related changes. There were small mammary adenomas in two females from the two lowest doses which were considered spontaneous. At the end of the study there were a significant relative kidney weight increase in females and relative liver weight increase in male and females at the 4000 ppm dose and consequently a NOAEL of 400 ppm or 30 mg/kg bw/day can be established.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
This website uses cookies to ensure you get the best experience on our websites.
Find out more on how we use cookies.